# Jinsheng Group

> Jinsheng Group is a VC fund in Hangzhou backing Life Science and Biotechnology. See 2 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Hangzhou, China
- Total investments: 2
- Last investment: Nov 2023
- Lead investor: 100%
- Last updated: Aug 2026

Jinsheng Group is an investment company.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 1 | 50% |
| Biotechnology | 1 | 50% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rigen Biotech | Rijing Biosciences has launched thyroid biopsy needles, multi-gene qPCR detection and NGS detection, Thyroscan® thyroid nodule benign and malignant classifier, and targeted surgery for thyroid cancer from preoperative sampling, diagnosis, to postoperative monitoring. Full-process series products such as post-recurrence monitoring provide a varietyof solutions for the entire thyroid cancer diagnosis and treatment cycle. |  | Series B | Nov 09, 2023 | http://www.rigen-bio.com/ |
| Derlead | Derlead is a biotechnology company that develops vitro diagnostic reagent products. |  | Series A | Jul 27, 2023 |  |

2 of 2 investments shown.

## Co-investors
- [Boyuan Capital](https://shizune.co/investors/profile/boyuan-capital-4fca) — VC Fund, 1 deal together
- [Zhejiang Synergy](https://shizune.co/investors/profile/zhejiang-synergy) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)
- [Life Science Investors in Asia](https://shizune.co/investors/life-science-investors-asia)

## FAQ

### What does Jinsheng Group invest in?

Jinsheng Group invests primarily in Life Science and Biotechnology startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jinsheng Group last invest?

The most recent investment recorded for Jinsheng Group closed in Nov 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co